Estimates Revisions WuXi Biologics (Cayman) Inc. OTC Markets
Stocks
WXXWY
US98260N1081
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.654 USD | +0.57% |
|
-0.79% | -5.50% |
| 02:12am | CANbridge Pharmaceuticals Enters Service Agreements With WuXi Biologics, Baheal Medical | MT |
| Jun. 05 | Wuxi Biologics Completes Topping Out of Drug Product Facility At Singapore Crdmo Hub | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- 2269 Stock
- WXXWY Stock
- Consensus WuXi Biologics (Cayman) Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
